Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Trafford

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Current Medical Research and Opinion|January 1, 1989
A multi-centre, placebo controlled comparative study between 200 mg and 400 mg celiprolol in patients with mild to moderate essential hypertensionJ A Trafford, D Latta, P S Little, et al.
The British Journal of Clinical Practice|October 1, 1982
A two year clinical evaluation of atenolol and metoprolol in the treatment of hypertensionJ A Trafford, R McGonigle, J Bowles, et al.
British Medical Journal (Clinical Research Ed.)|April 4, 1981
Five year follow-up of effects of treatment of mild and moderate hypertensionJ A Trafford, C R Horn, H O'Neal, et al.
The Quarterly Journal of Medicine|October 1, 1989
Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatmentN Iggo, A B Palmer, A Severn, et al.
The Journal of Organic Chemistry|February 19, 2014
Melamine and melamine-formaldehyde polymers as ligands for palladium and application to Suzuki-Miyaura cross-coupling reactions in sustainable solventsGrant A Edwards, Mitchell A Trafford, Alaina E Hamilton, et al.
Nature Communications|August 14, 2021
Macroscopic weavable fibers of carbon nanotubes with giant thermoelectric power factorNatsumi Komatsu, Yota Ichinose, Oliver S Dewey, et al.
The Journal of the Royal College of General Practitioners|October 1, 1979
The treatment of hypertension with propranolol and bendrofluazideR L Agrawal, R J Alliott, M George, et al.
British Journal of Pharmacology|February 11, 2011
How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?Hg Laverty, C Benson, Ej Cartwright, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Current Medical Research and Opinion|January 1, 1989
A multi-centre, placebo controlled comparative study between 200 mg and 400 mg celiprolol in patients with mild to moderate essential hypertensionJ A Trafford, D Latta, P S Little, et al.
The British Journal of Clinical Practice|October 1, 1982
A two year clinical evaluation of atenolol and metoprolol in the treatment of hypertensionJ A Trafford, R McGonigle, J Bowles, et al.
British Medical Journal (Clinical Research Ed.)|April 4, 1981
Five year follow-up of effects of treatment of mild and moderate hypertensionJ A Trafford, C R Horn, H O'Neal, et al.
The Quarterly Journal of Medicine|October 1, 1989
Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatmentN Iggo, A B Palmer, A Severn, et al.
The Journal of Organic Chemistry|February 19, 2014
Melamine and melamine-formaldehyde polymers as ligands for palladium and application to Suzuki-Miyaura cross-coupling reactions in sustainable solventsGrant A Edwards, Mitchell A Trafford, Alaina E Hamilton, et al.
Nature Communications|August 14, 2021
Macroscopic weavable fibers of carbon nanotubes with giant thermoelectric power factorNatsumi Komatsu, Yota Ichinose, Oliver S Dewey, et al.
The Journal of the Royal College of General Practitioners|October 1, 1979
The treatment of hypertension with propranolol and bendrofluazideR L Agrawal, R J Alliott, M George, et al.
British Journal of Pharmacology|February 11, 2011
How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?Hg Laverty, C Benson, Ej Cartwright, et al.
Pageof 6